Long-term survival and cure fraction in patients with advanced hepatocellular carcinoma under immunotherapy in randomized controlled trials and real-world data

已完结 20 由 Cefradine1005 发布于 2026/7/19 16:23:52

DOI:10.1158/1078-0432.ccr-25-4943
作者：Claudia Campani, Ju Hyun Shim, Mohamed Bouattour, Yann Touchefeu, Victoria Delhoume, Olivier Rosmorduc, Alina Pascale, Jihyun An, Han Chu Lee, Helene Regnault, Dominique Thabut, Giuliana Amaddeo, Mass
文献类型：期刊论文
补充材料：只需要正文

American Association for Cancer Research (AACR)

Abstract：Background Aims: Immune checkpoint inhibitors (ICIs) can induce long-term survival and even cancer cure in several cancers. Mixture cure models (MCMs) estimate the fraction of long-term sur

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierProtective effects of silibinin against ethanol- or acetaldehyde-caused damage in liver cell lines involve the repression of mitochondrial fission